Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study

Monitoring of Immune Responses Following Mogamulizumab-Containing Treatment in Patients with Adult T-Cell Leukemia-Lymphoma (ATL) (MIMOGA) is a multicenter prospective observational study to establish the most effective and safe treatment strategy using mogamulizumab for ATL patients (UMIN000008696)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Yonekura, Kentaro, Kusumoto, Shigeru, Choi, Ilseung, Nakano, Nobuaki, Ito, Asahi, Suehiro, Youko, Imaizumi, Yoshitaka, Yoshimitsu, Makoto, Nosaka, Kisato, Ohtsuka, Eiichi, Hidaka, Michihiro, Jo, Tatsuro, Sasaki, Hidenori, Moriuchi, Yukiyoshi, Ogata, Masao, Tatetsu, Hiro, Ishitsuka, Kenji, Miyazaki, Yasushi, Ueda, Ryuzo, Utsunomiya, Atae, Ishida, Takashi
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Immunobiology and Immunotherapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594399/
https://ncbi.nlm.nih.gov/pubmed/33091125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003053
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars